{
    "company_name": "MEMPHASYS LIMITED.",
    "address": "30 -32 Richmond Road, HOMEBUSH WEST, NSW, AUSTRALIA, 2140",
    "summary": "Memphasys Limited (ASX:MEM) specialises in biological separations for commercial applications.  The Company's patented membrane processes enable the selection of high value substances or contaminants from the fluid in which they are contained.",
    "details": "Memphasys Limited (ASX:MEM) specialises in biological separations for commercial applications.  The Company's patented membrane processes enable the selection of high value substances or contaminants from the fluid in which they are contained.",
    "website": "http://www.memphasys.com/",
    "stock_code": "MEM",
    "links": "['https://www.memphasys.com/', '#', 'https://www.memphasys.com/', 'https://www.memphasys.com/about-us/', 'https://www.memphasys.com/about-us/purpose-statement/', 'https://www.memphasys.com/about-us/global-markets-trends-humans/', 'https://www.memphasys.com/board-of-directors/', 'https://www.memphasys.com/product/', 'https://www.memphasys.com/about-us/what-we-do-humans/', 'https://www.memphasys.com/about-us/what-we-do-animals/', 'https://www.memphasys.com/john-aitken/', 'https://www.memphasys.com/about-us/ip-and-patents/', 'https://www.memphasys.com/about-us/regulatory-plan/', 'https://www.memphasys.com/corporate-partners/', 'https://www.memphasys.com/distribution/', 'https://www.memphasys.com/resource-centre/', 'https://www.memphasys.com/resource-centre/publications/', 'https://www.memphasys.com/resource-centre/news-and-articles/', 'https://www.memphasys.com/resource-centre/case-studies/', 'https://www.memphasys.com/resource-centre/technology-developments-white-papers-and-research/', 'https://www.memphasys.com/resource-centre/awards/', 'https://www.memphasys.com/resource-centre/felix-system-operation-japanese/', 'https://www.memphasys.com/resource-centre/felix-system-operation-chinese/', 'https://www.memphasys.com/investor-relations/', 'https://www.memphasys.com/investor-relations/asx-announcements/', 'https://www.memphasys.com/investor-relations/annual-reports-and-agm/', 'https://www.memphasys.com/investor-relations/corporate-governance/', 'https://www.memphasys.com/contact-us/', 'https://www.memphasys.com/', '#', 'https://www.memphasys.com/about-us/', 'https://www.memphasys.com/new-japanese-partnership-joins-the-memphasys-revolution-in-ivf-sperm-separation-technology/', 'https://www.memphasys.com/resource-centre/case-studies/case-study-felix%ef%b8%8f-device/', 'https://www.memphasys.com/wp-content/uploads/2023/03/piezo-felix.pdf', 'https://www.memphasys.com/resource-centre/case-studies/case-study-felix%ef%b8%8f-device/', 'https://www.memphasys.com/about-us/what-we-do-humans/', 'https://www.memphasys.com/about-us/what-we-do-animals/', 'https://www.memphasys.com/about-us/what-we-do-animals/', 'https://www.memphasys.com/john-aitken/', 'https://www.memphasys.com/wp-content/uploads/2023/09/2609383.pdf', 'https://www.memphasys.com/wp-content/uploads/2023/09/2609383.pdf', 'https://www.memphasys.com/advancing-partnership-memphasys-visits-manufacturing-partner/', 'https://www.memphasys.com/advancing-partnership-memphasys-visits-manufacturing-partner/', 'https://www.memphasys.com/advancing-partnership-memphasys-visits-manufacturing-partner/', 'https://www.memphasys.com/memphasys-visit-monash-ivf-cementing-our-clinical-partnership/', 'https://www.memphasys.com/memphasys-visit-monash-ivf-cementing-our-clinical-partnership/', 'https://www.memphasys.com/memphasys-visit-monash-ivf-cementing-our-clinical-partnership/', 'https://www.memphasys.com/memphasys-tools-up-for-more-growth-as-leadership-restructure-sees-dr-david-ali-move-to-acting-ceo-executive-director/', 'https://www.memphasys.com/memphasys-tools-up-for-more-growth-as-leadership-restructure-sees-dr-david-ali-move-to-acting-ceo-executive-director/', 'https://www.memphasys.com/memphasys-tools-up-for-more-growth-as-leadership-restructure-sees-dr-david-ali-move-to-acting-ceo-executive-director/', 'https://www.memphasys.com/advancing-artificial-insemination-the-ai-port-spring-trial-shows-promise/', 'https://www.memphasys.com/advancing-artificial-insemination-the-ai-port-spring-trial-shows-promise/', 'https://www.memphasys.com/advancing-artificial-insemination-the-ai-port-spring-trial-shows-promise/', 'https://www.memphasys.com/about-us/', 'https://www.memphasys.com/product/', 'https://www.memphasys.com/corporate-partners/', 'https://www.memphasys.com/resource-centre/', 'https://www.memphasys.com/investor-relations/', 'https://www.memphasys.com/contact-us/', 'tel: 61 2 8415 7300', 'https://www.memphasys.com/terms-and-conditions/', 'https://lock-stock.com.au/', '#']",
    "images": "https://www.memphasys.com/wp-content/uploads/2021/12/Memphasys-Logo-Positive.png, https://www.memphasys.com/wp-content/uploads/2021/12/Memphasys-Logo-Negative.png, https://www.memphasys.com/wp-content/plugins/translatepress-multilingual/assets/images/flags/en_AU.png, https://www.memphasys.com/wp-content/uploads/2022/01/Memphasys-Lock-Stock-Babies-Artificial-Insemintaion-uai-1620x1080.jpg, https://www.memphasys.com/wp-content/uploads/2021/12/Memphasys-Cow-uai-563x563.jpg, https://www.memphasys.com/wp-content/uploads/2021/12/Memphasys-Horses-uai-563x563.jpg, https://www.memphasys.com/wp-content/uploads/2021/12/r2_185_3618_2228_w1200_h678_fmax.jpeg, https://www.memphasys.com/wp-content/uploads/2023/09/1.png, https://www.memphasys.com/wp-content/uploads/2023/09/image-2.png, https://www.memphasys.com/wp-content/uploads/2024/01/WhatsApp-Image-2024-02-14-at-21.36.29_ecd7f049-uai-1600x1066.jpg, https://www.memphasys.com/wp-content/uploads/2024/02/WhatsApp-Image-2024-02-15-at-13.33.58_8ffda6aa-uai-1200x800.jpg, https://www.memphasys.com/wp-content/uploads/2024/02/WhatsApp-Image-2024-02-15-at-13.34.13_13da078e-uai-1200x800.jpg, https://www.memphasys.com/wp-content/uploads/2024/02/710450-2-uai-675x450.png",
    "company_logo_link": "https://www.memphasys.com/wp-content/uploads/2021/12/Memphasys-Logo-Positive.png"
}